Medications
Signifor approved for Cushing's disease
(HealthDay)—Signifor (pasireotide diaspartate) has been approved by the U.S. Food and Drug Administration to treat Cushing's disease in cases that cannot be treated by surgery.
Dec 17, 2012
0
0
News tagged with novartis
Medications
Predicting liver injury in paracetamol overdose patients
Scientists at the University of Liverpool have identified molecules in the blood that could help predict the risk of a patient developing liver injury eight hours after a paracetamol overdose.
Feb 22, 2013
0
0
Other
Novartis to buy US pharma group Chinook Therapeutics
Swiss pharmaceutical giant Novartis said Monday that it had reached a deal to buy US kidney treatment developer Chinook Therapeutics for up to $3.5 billion.
Jun 12, 2023
0
2
Oncology & Cancer
Gleevec's latest approval is for pediatric cancer
(HealthDay)—The anti-cancer drug Gleevec (imatinib) has received new U.S. Food and Drug Administration approval to treat the most common type of pediatric cancer, affecting some 2,900 children each year, the agency said ...
Jan 25, 2013
0
0
Medications
Novartis chief sees sales dip until mid-2013
Swiss pharmaceutical giant Novartis said Sunday the expiry of a US patent for its leading hypertension drug Diovan caused a drop in turnover that could last into the first half of 2013.
Oct 7, 2012
0
0
Diseases, Conditions, Syndromes
New strategy to disarm the dengue virus brings new hope for a universal dengue vaccine
A new strategy that cripples the ability of the dengue virus to escape the host immune system has been discovered by A*STAR's Singapore Immunology Network (SIgN). This breakthrough strategy opens a door of hope to what may ...
Aug 13, 2013
0
0
Medications
Novartis to use Google technology for eye care
Swiss drug developer Novartis will team with technology giant Google to develop a "smart" contact lens that could improve some eye conditions or help diabetics manage their disease.
Jul 15, 2014
0
0
Alzheimer's disease & dementia
New Japan research scandal brewing over Alzheimer's study
Japan's health ministry said Friday it was probing claims falsified data was used in an Alzheimer's disease study involving major pharmaceutical firms, a day after filing an unrelated criminal complaint against Swiss drugs ...
Jan 10, 2014
0
0
Medications
FDA panel endorses first lower-cost biotech drug
Federal health experts have unanimously endorsed a Novartis drug which is expected to become the first lower-cost copy of a biotech drug to reach the U.S. market.
Jan 7, 2015
0
10
Cardiology
FDA approves new heart failure pill from Novartis
Government regulators have approved a new pill from Novartis to treat heart failure, a deadly chronic disease that affects millions of U.S. patients.
Jul 7, 2015
0
6
